UniProt ID | PIPNB_HUMAN | |
---|---|---|
UniProt AC | P48739 | |
Protein Name | Phosphatidylinositol transfer protein beta isoform | |
Gene Name | PITPNB | |
Organism | Homo sapiens (Human). | |
Sequence Length | 271 | |
Subcellular Localization | Cytoplasm. Golgi apparatus. | |
Protein Description | Catalyzes the transfer of PtdIns and phosphatidylcholine between membranes.. | |
Protein Sequence | MVLIKEFRVVLPCSVQEYQVGQLYSVAEASKNETGGGEGIEVLKNEPYEKDGEKGQYTHKIYHLKSKVPAFVRMIAPEGSLVFHEKAWNAYPYCRTIVTNEYMKDDFFIKIETWHKPDLGTLENVHGLDPNTWKTVEIVHIDIADRSQVEPADYKADEDPALFQSVKTKRGPLGPNWKKELANSPDCPQMCAYKLVTIKFKWWGLQSKVENFIQKQEKRIFTNFHRQLFCWIDKWIDLTMEDIRRMEDETQKELETMRKRGSVRGTSAADV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Acetylation | ---MVLIKEFRVVLP ---CCEEEEEEEEEE | 46.79 | 19608861 | |
5 | Ubiquitination | ---MVLIKEFRVVLP ---CCEEEEEEEEEE | 46.79 | 23000965 | |
5 (in isoform 2) | Ubiquitination | - | 46.79 | - | |
13 | Glutathionylation | EFRVVLPCSVQEYQV EEEEEEEECCEEEEC | 5.64 | 22555962 | |
18 | Phosphorylation | LPCSVQEYQVGQLYS EEECCEEEECCCEEE | 7.45 | - | |
31 | Ubiquitination | YSVAEASKNETGGGE EEHHHHHCCCCCCCC | 66.89 | 32015554 | |
33 | Ubiquitination | VAEASKNETGGGEGI HHHHHCCCCCCCCCE | 53.19 | 32015554 | |
44 | Ubiquitination | GEGIEVLKNEPYEKD CCCEEEECCCCCCCC | 65.52 | 21906983 | |
44 | Acetylation | GEGIEVLKNEPYEKD CCCEEEECCCCCCCC | 65.52 | 23236377 | |
44 (in isoform 1) | Ubiquitination | - | 65.52 | 21890473 | |
46 | Ubiquitination | GIEVLKNEPYEKDGE CEEEECCCCCCCCCC | 47.90 | 29967540 | |
46 (in isoform 2) | Ubiquitination | - | 47.90 | 21890473 | |
50 | Ubiquitination | LKNEPYEKDGEKGQY ECCCCCCCCCCCCCC | 66.25 | 22817900 | |
50 | Acetylation | LKNEPYEKDGEKGQY ECCCCCCCCCCCCCC | 66.25 | 22424773 | |
52 | Ubiquitination | NEPYEKDGEKGQYTH CCCCCCCCCCCCCEE | 49.97 | 22817900 | |
54 | Ubiquitination | PYEKDGEKGQYTHKI CCCCCCCCCCCEEEE | 57.77 | 22817900 | |
56 | Ubiquitination | EKDGEKGQYTHKIYH CCCCCCCCCEEEEEE | 51.52 | 22817900 | |
57 | Phosphorylation | KDGEKGQYTHKIYHL CCCCCCCCEEEEEEH | 21.34 | 22817900 | |
58 | Phosphorylation | DGEKGQYTHKIYHLK CCCCCCCEEEEEEHH | 14.59 | 22817900 | |
60 | Ubiquitination | EKGQYTHKIYHLKSK CCCCCEEEEEEHHHC | 36.84 | 29967540 | |
62 | Ubiquitination | GQYTHKIYHLKSKVP CCCEEEEEEHHHCCC | 13.10 | 29967540 | |
65 | Ubiquitination | THKIYHLKSKVPAFV EEEEEEHHHCCCEEE | 34.61 | 29967540 | |
67 | Ubiquitination | KIYHLKSKVPAFVRM EEEEHHHCCCEEEEE | 51.13 | 32142685 | |
67 (in isoform 2) | Ubiquitination | - | 51.13 | - | |
69 | Ubiquitination | YHLKSKVPAFVRMIA EEHHHCCCEEEEEEC | 24.58 | 32142685 | |
74 | Sulfoxidation | KVPAFVRMIAPEGSL CCCEEEEEECCCCCE | 2.29 | 21406390 | |
80 | Phosphorylation | RMIAPEGSLVFHEKA EEECCCCCEEEECCC | 21.50 | 23532336 | |
86 | Ubiquitination | GSLVFHEKAWNAYPY CCEEEECCCHHHCCC | 50.56 | 23000965 | |
86 (in isoform 2) | Ubiquitination | - | 50.56 | - | |
86 | Acetylation | GSLVFHEKAWNAYPY CCEEEECCCHHHCCC | 50.56 | 26051181 | |
86 (in isoform 1) | Ubiquitination | - | 50.56 | 21890473 | |
88 | Ubiquitination | LVFHEKAWNAYPYCR EEEECCCHHHCCCEE | 10.89 | 23000965 | |
88 | Ubiquitination | LVFHEKAWNAYPYCR EEEECCCHHHCCCEE | 10.89 | 21890473 | |
88 (in isoform 2) | Ubiquitination | - | 10.89 | 21890473 | |
91 | Phosphorylation | HEKAWNAYPYCRTIV ECCCHHHCCCEEEEE | 7.48 | 28152594 | |
93 | Phosphorylation | KAWNAYPYCRTIVTN CCHHHCCCEEEEECC | 5.06 | 20090780 | |
96 | Phosphorylation | NAYPYCRTIVTNEYM HHCCCEEEEECCCHH | 19.08 | - | |
104 | Methylation | IVTNEYMKDDFFIKI EECCCHHCCCEEEEE | 53.92 | 44498999 | |
104 | Ubiquitination | IVTNEYMKDDFFIKI EECCCHHCCCEEEEE | 53.92 | 23000965 | |
104 (in isoform 2) | Ubiquitination | - | 53.92 | - | |
104 (in isoform 1) | Ubiquitination | - | 53.92 | 21890473 | |
106 | Ubiquitination | TNEYMKDDFFIKIET CCCHHCCCEEEEEEE | 34.53 | 21890473 | |
106 | Ubiquitination | TNEYMKDDFFIKIET CCCHHCCCEEEEEEE | 34.53 | 21890473 | |
106 (in isoform 2) | Ubiquitination | - | 34.53 | 21890473 | |
110 | Ubiquitination | MKDDFFIKIETWHKP HCCCEEEEEEEECCC | 29.36 | 23000965 | |
110 (in isoform 1) | Ubiquitination | - | 29.36 | 21890473 | |
112 | Ubiquitination | DDFFIKIETWHKPDL CCEEEEEEEECCCCC | 40.62 | 23000965 | |
112 | Ubiquitination | DDFFIKIETWHKPDL CCEEEEEEEECCCCC | 40.62 | 21890473 | |
112 (in isoform 2) | Ubiquitination | - | 40.62 | 21890473 | |
116 | Ubiquitination | IKIETWHKPDLGTLE EEEEEECCCCCCCEE | 31.61 | 29967540 | |
116 | Acetylation | IKIETWHKPDLGTLE EEEEEECCCCCCCEE | 31.61 | 26051181 | |
118 | Ubiquitination | IETWHKPDLGTLENV EEEECCCCCCCEECC | 63.63 | 29967540 | |
146 | Methylation | VHIDIADRSQVEPAD EEEECCCHHHCCCCC | 21.70 | 115487603 | |
154 | Phosphorylation | SQVEPADYKADEDPA HHCCCCCCCCCCCHH | 15.35 | - | |
155 | Ubiquitination | QVEPADYKADEDPAL HCCCCCCCCCCCHHH | 50.32 | 21906983 | |
155 (in isoform 2) | Ubiquitination | - | 50.32 | - | |
155 (in isoform 1) | Ubiquitination | - | 50.32 | 21890473 | |
157 | Ubiquitination | EPADYKADEDPALFQ CCCCCCCCCCHHHHH | 57.59 | 21963094 | |
157 | Ubiquitination | EPADYKADEDPALFQ CCCCCCCCCCHHHHH | 57.59 | 21890473 | |
157 (in isoform 2) | Ubiquitination | - | 57.59 | 21890473 | |
167 | Ubiquitination | PALFQSVKTKRGPLG HHHHHHHCCCCCCCC | 54.28 | 21906983 | |
167 (in isoform 1) | Ubiquitination | - | 54.28 | 21890473 | |
169 | Ubiquitination | LFQSVKTKRGPLGPN HHHHHCCCCCCCCCC | 50.03 | 24816145 | |
169 (in isoform 2) | Ubiquitination | - | 50.03 | 21890473 | |
169 | Ubiquitination | LFQSVKTKRGPLGPN HHHHHCCCCCCCCCC | 50.03 | 21890473 | |
178 | Ubiquitination | GPLGPNWKKELANSP CCCCCCHHHHHCCCC | 42.90 | 23000965 | |
179 | Ubiquitination | PLGPNWKKELANSPD CCCCCHHHHHCCCCC | 49.96 | 23000965 | |
179 (in isoform 2) | Ubiquitination | - | 49.96 | - | |
179 (in isoform 1) | Ubiquitination | - | 49.96 | 21890473 | |
180 | Ubiquitination | LGPNWKKELANSPDC CCCCHHHHHCCCCCC | 49.76 | 23000965 | |
181 | Ubiquitination | GPNWKKELANSPDCP CCCHHHHHCCCCCCH | 8.20 | 23000965 | |
181 | Ubiquitination | GPNWKKELANSPDCP CCCHHHHHCCCCCCH | 8.20 | 21890473 | |
181 (in isoform 2) | Ubiquitination | - | 8.20 | 21890473 | |
184 | Phosphorylation | WKKELANSPDCPQMC HHHHHCCCCCCHHHH | 19.26 | 25159151 | |
193 | Phosphorylation | DCPQMCAYKLVTIKF CCHHHHHHHEEEEEH | 10.42 | 18083107 | |
194 | Acetylation | CPQMCAYKLVTIKFK CHHHHHHHEEEEEHH | 20.25 | 26051181 | |
199 | Ubiquitination | AYKLVTIKFKWWGLQ HHHEEEEEHHHHCCH | 31.37 | 23000965 | |
199 | Acetylation | AYKLVTIKFKWWGLQ HHHEEEEEHHHHCCH | 31.37 | 25953088 | |
201 | Ubiquitination | KLVTIKFKWWGLQSK HEEEEEHHHHCCHHH | 36.71 | 23000965 | |
201 (in isoform 2) | Ubiquitination | - | 36.71 | - | |
201 | Acetylation | KLVTIKFKWWGLQSK HEEEEEHHHHCCHHH | 36.71 | 25953088 | |
201 (in isoform 1) | Ubiquitination | - | 36.71 | 21890473 | |
203 | Ubiquitination | VTIKFKWWGLQSKVE EEEEHHHHCCHHHHH | 9.75 | 23000965 | |
203 | Ubiquitination | VTIKFKWWGLQSKVE EEEEHHHHCCHHHHH | 9.75 | 21890473 | |
203 (in isoform 2) | Ubiquitination | - | 9.75 | 21890473 | |
208 | Ubiquitination | KWWGLQSKVENFIQK HHHCCHHHHHHHHHH | 40.38 | 23000965 | |
208 (in isoform 2) | Ubiquitination | - | 40.38 | - | |
208 (in isoform 1) | Ubiquitination | - | 40.38 | 21890473 | |
210 | Ubiquitination | WGLQSKVENFIQKQE HCCHHHHHHHHHHHH | 50.59 | 23000965 | |
210 | Ubiquitination | WGLQSKVENFIQKQE HCCHHHHHHHHHHHH | 50.59 | 21890473 | |
210 (in isoform 2) | Ubiquitination | - | 50.59 | 21890473 | |
215 | Acetylation | KVENFIQKQEKRIFT HHHHHHHHHHHHHHH | 56.46 | 19608861 | |
215 | Ubiquitination | KVENFIQKQEKRIFT HHHHHHHHHHHHHHH | 56.46 | 23000965 | |
215 (in isoform 2) | Ubiquitination | - | 56.46 | - | |
215 (in isoform 1) | Ubiquitination | - | 56.46 | 21890473 | |
217 | Ubiquitination | ENFIQKQEKRIFTNF HHHHHHHHHHHHHHH | 51.87 | 23000965 | |
217 | Ubiquitination | ENFIQKQEKRIFTNF HHHHHHHHHHHHHHH | 51.87 | 21890473 | |
217 | Acetylation | ENFIQKQEKRIFTNF HHHHHHHHHHHHHHH | 51.87 | 19608861 | |
217 (in isoform 2) | Ubiquitination | - | 51.87 | 21890473 | |
218 | Ubiquitination | NFIQKQEKRIFTNFH HHHHHHHHHHHHHHH | 48.58 | 23000965 | |
218 (in isoform 2) | Ubiquitination | - | 48.58 | - | |
220 | Ubiquitination | IQKQEKRIFTNFHRQ HHHHHHHHHHHHHHH | 8.06 | 23000965 | |
220 | Ubiquitination | IQKQEKRIFTNFHRQ HHHHHHHHHHHHHHH | 8.06 | - | |
240 | Sulfoxidation | DKWIDLTMEDIRRME HHHHCCCHHHHHHCC | 5.91 | 30846556 | |
244 | Methylation | DLTMEDIRRMEDETQ CCCHHHHHHCCHHHH | 44.19 | 115487611 | |
250 | Phosphorylation | IRRMEDETQKELETM HHHCCHHHHHHHHHH | 58.21 | 20068231 | |
252 | Ubiquitination | RMEDETQKELETMRK HCCHHHHHHHHHHHH | 72.23 | 29967540 | |
252 (in isoform 1) | Ubiquitination | - | 72.23 | 21890473 | |
254 | Ubiquitination | EDETQKELETMRKRG CHHHHHHHHHHHHHC | 9.52 | 21890473 | |
254 | Ubiquitination | EDETQKELETMRKRG CHHHHHHHHHHHHHC | 9.52 | 21890473 | |
254 (in isoform 2) | Ubiquitination | - | 9.52 | 21890473 | |
256 | Phosphorylation | ETQKELETMRKRGSV HHHHHHHHHHHHCCC | 34.59 | 20068231 | |
262 | Phosphorylation | ETMRKRGSVRGTSAA HHHHHHCCCCCCCCC | 16.81 | 28355574 | |
266 | Phosphorylation | KRGSVRGTSAADV-- HHCCCCCCCCCCC-- | 12.48 | 25159151 | |
267 | Phosphorylation | RGSVRGTSAADV--- HCCCCCCCCCCC--- | 25.04 | 23403867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PIPNB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
262 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PIPNB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of PIPNB_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5 AND LYS-215, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-57, AND MASSSPECTROMETRY. |